KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $6.00

KORU Medical Systems (NASDAQ:KRMD) had its target price hoisted by Craig Hallum from $5.00 to $6.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the company. Lake Street Capital increased their target price on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. Piper Sandler increased their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a report on Thursday, November 14th. Finally, Canaccord Genuity Group raised their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $4.50.

KORU Medical Systems Price Performance

KRMD stock opened at $4.09 on Friday. The stock has a 50-day moving average price of $3.82 and a two-hundred day moving average price of $2.98. The stock has a market cap of $187.49 million, a PE ratio of -16.36 and a beta of 0.45. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a 1 year low of $1.98 and a 1 year high of $4.60.

Hedge Funds Weigh In On KORU Medical Systems

Hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC lifted its stake in KORU Medical Systems by 6.5% in the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after purchasing an additional 28,323 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after purchasing an additional 26,860 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in KORU Medical Systems in the 2nd quarter valued at about $107,000. Meros Investment Management LP lifted its stake in KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after purchasing an additional 137,918 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in KORU Medical Systems in the 3rd quarter valued at about $34,000. Institutional investors own 58.60% of the company’s stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.